Estratriene derivatives

Details for Australian Patent Application No. 2004238395 (hide)

Owner Cryptopharma Pty Ltd

Inventors McAllister, David James; Stewart, Alastair George; Lambert, John Nicholas

Agent Blake Dawson Waldron

Pub. Number AU-A-2004238395

PCT Pub. Number WO2004/101595

Priority 60/470,379 13.05.03 US

Filing date 13 May 2004

Wipo publication date 25 November 2004

International Classifications

C07J 041/00 Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

A61K 031/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07J 043/00 Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton

A61P 011/06 Drugs for disorders of the respiratory system

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/101595 Priority application(s): WO2004/101595

9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238398-Novelty article and product promotion using the novelty article

2004238393-Improved assembly and disassembly method, system and component